Back

Poor prognosis of total culprit artery occlusion in patients presenting with NSTEMI

28 August 2023 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Risk stratification in acute coronary syndromes (4) Non-ST-Elevation Myocardial Infarction (NSTEMI) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Robert Herman

Cardiovascular Research Center Aalst, Aalst (Belgium)

6 More presentations in this session

Presentation thumbnail
The impact of smoking status on platelet reactivity and its association on clinical outcomes in east asian AMI patients with stent implantation
Doctor Z. Song (Busan, KR)
Abstract Slides Video
Presentation thumbnail
Abscence of high lipoprotein(a) levels is and independent predictor of acute myocardial infarction without coronary lesions
Doctor A. Kallmeyer (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Long-term prognostic value of white blood cell count variation during hospital stay in patients with STEMI
Doctor M. Boukhris (Limoges, FR)
Abstract Slides Video
Presentation thumbnail
Predictive value of STEP-HF risk score in patients with ST-segment elevation myocardial infarction (Killip I) treated by primary percutaneous coronary intervention
Professor J. Chen (Wuhan, CN)
Abstract Slides Video
Presentation thumbnail
Uncertain meaning of early Q-wave in STEMI. Can we still rely on its relevance?
Doctor K. Pupiales Davila (Mexico City, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in acute coronary syndromes (4)

The Event

Event poster

ESC Congress 2023

28 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Reassessing ACS: the role of coronary occlusion in risk stratification and management
thumbnail
Congress Presentation
Clinical characteristics and outcomes of NSTEMI patients with acute total occlusion
thumbnail
Congress Presentation
5-year mortality after ST-segment elevation myocardial infarction compared to the general population

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources